Literature DB >> 28708784

Apoptotic Diminution of Immature Single and Double Positive Thymocyte Subpopulations Contributes to Thymus Involution During Murine Polymicrobial Sepsis.

Christoph Netzer1, Tilo Knape, Laura Kuchler, Andreas Weigert, Kai Zacharowski, Waltraud Pfeilschifter, Gregory Sempowski, Michael J Parnham, Bernhard Brüne, Andreas von Knethen.   

Abstract

To generate and maintain functional T-cell receptor diversity, thymocyte development is tightly organized. Errors in this process may have dramatic consequences, provoking, for example, autoimmune diseases. Probably for this reason, the thymus reacts to septic stress with involution, decreasing the numbers of thymocytes. Because it is still unclear which thymocyte subpopulation contributes to thymus involution and whether thymocyte emigration is altered, we were interested to clarify this question in detail. Here, we show, using the cecal ligation and puncture (CLP) mouse model of polymicrobial sepsis, that predominantly immature thymocytes are reduced. The number of immature single positive thymocytes was most marked diminished (CLP: 6.54 × 10 ± 3.79 × 10 vs. sham: 4.54 × 10 ± 7.66 × 10 cells/thymus [24 h], CLP: 2.60 × 10 ± 2.14 × 10 vs. sham: 2.17 × 10 ± 1.90 × 10 cells/thymus [48 h]), and was consequently associated with the highest rate of apoptosis (8.4 [CLP] vs. 2.2% [sham]), the reduction in double positive thymocytes being associated with a smaller apoptotic response (number, CLP: 2.33 × 10 ± 1.38 × 10 vs. sham: 1.07 × 10 ± 2.72 × 10 cells/thymus [24 h], CLP: 2.34 × 10 ± 9.08 × 10 vs. sham: 3.5 × 10 ± 9.62 × 10 cells/thymus [48 h]; apoptosis: 2.5% [CLP] vs. 0.7% [sham]). Analysis of T-cell receptor excision circles revealed that the emigration of mature thymocytes was not inhibited. Real-time qPCR analysis revealed upregulation of pro-apoptotic Bim expression and suggested interference between Notch receptor expression on thymocytes and the respective ligands on thymic stromal cells during CLP-dependent sepsis, which might be responsible for the altered thymocyte viability in CLP-dependent sepsis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708784      PMCID: PMC6263038          DOI: 10.1097/SHK.0000000000000842

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  33 in total

Review 1.  T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation.

Authors:  M D Hazenberg; M C Verschuren; D Hamann; F Miedema; J J van Dongen
Journal:  J Mol Med (Berl)       Date:  2001-11       Impact factor: 4.599

2.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 3.  Fas-ligand mediated apoptosis in severe sepsis and shock.

Authors:  Alfred Ayala; Joanne L Lomas; Patricia S Grutkoski; Shiang Chung
Journal:  Scand J Infect Dis       Date:  2003

Review 4.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

5.  A central role for thymic emigrants in peripheral T cell homeostasis.

Authors:  S P Berzins; D I Godfrey; J F Miller; R L Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

6.  Expression of early activation antigen (CD69) during human thymic development.

Authors:  L K Jung; B F Haynes; S Nakamura; S Pahwa; S M Fu
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  T cell receptor excision circle assessment of thymopoiesis in aging mice.

Authors:  Gregory D Sempowski; Maria E Gooding; H X Liao; Phong T Le; Barton F Haynes
Journal:  Mol Immunol       Date:  2002-03       Impact factor: 4.407

8.  Kinetics of thymocyte developmental process in fetal and neonatal mice.

Authors:  Shi Yun Xiao; Yan Li; Wei Feng Chen
Journal:  Cell Res       Date:  2003-08       Impact factor: 25.617

9.  Sepsis-induced apoptosis of the thymocytes in mice.

Authors:  S D Wang; K J Huang; Y S Lin; H Y Lei
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

10.  Post-thymic T lymphocyte maturation during ontogenesis.

Authors:  P F Piguet; C Irle; E Kollatte; P Vassalli
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

Review 2.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

3.  Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway.

Authors:  Timothy H Ciesielski; Xueyi Zhang; Scott M Williams; Giorgio Sirugo; Alessandra Tacconelli; Irja Lutsar; Vincent Meiffredy de Cabre; Emmanuel Roilides; Cinzia Ciccacci; Paola Borgiani; William K Scott
Journal:  Pediatr Res       Date:  2022-07-14       Impact factor: 3.953

4.  Hepatic pannexin-1 mediates ST2+ regulatory T cells promoting resolution of inflammation in lipopolysaccharide-induced endotoxemia.

Authors:  Pusen Wang; Baojie Shi; Chunguang Wang; Yuanyuan Wang; Weitao Que; Zhongyi Jiang; Xueni Liu; Qianwei Jiang; Hao Li; Zhihai Peng; Lin Zhong
Journal:  Clin Transl Med       Date:  2022-05

5.  The potential mechanism of extracellular high mobility group box-1 protein mediated p53 expression in immune dysfunction of T lymphocytes.

Authors:  Ying-Yi Luan; Min Jia; Hui Zhang; Fu-Jun Zhu; Ning Dong; Yong-Wen Feng; Ming Wu; Ya-Lin Tong; Yong-Ming Yao
Journal:  Oncotarget       Date:  2017-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.